Abstract. Gastrin-releasing peptide (GRP) has been suggested as a novel regulatory peptide in the female reproductive tract but the presence of GRP and GRP mRNA in the non-neurogenic tissue of the cervix has not yet been clarified. In the present study, immunohistochemistry and in situ hybridization were used to reveal the distribution of GRP immunoreactivity and expression of GRP mRNA in the bovine cervix. The cervixes from 21 non-pregnant and 20 pregnant cows, and 6 fetuses were used in the study. In the fetus, adult non-pregnant and pregnant specimens, GRP and GRP mRNA were predominantly detected in the luminal epithelial cells of basal areas of peripheral regions of the cervix. Positive staining of GRP in the epithelial cells of the cervix was first detected in the CRL 37 cm of the fetus. During the estrous cycles, the staining intensity of GRP in the epithelial cells was stronger in the follicular phase than in the luteal phase. During the early gestational period, GRP immunoreactivity was detected at relatively similar intensity to the follicular phase. In situ hybridization results ascertained the expression of GRP mRNA in the superficial epithelial cells of the cervix of non-pregnant and pregnant cows. The results suggest that GRP may be important both in the development of the fetal cervix and secretory activity of the epithelial cells of the cervix. Key words: Cervix, Gastrin-releasing peptide (GRP), Immunohistochemistry, In situ hybridization (J. Reprod. Dev. 50: [119][120][121][122][123][124][125][126][127][128][129] 2004) astrin-releasing peptide (GRP) is a member of the bombesin (BN)-like peptide family in mammals. A novel active polypeptide, BN was found for the first time in the skin of the European amphibian, Bombina bombina [1] . Other peptides related to BN were purified from amphibians, and classified into two other families, ranatensin and phyllolitorin families [2] [3] [4] . Among these three BNlike peptide families, mammalian homologues were found only fo r the BN and ranatensin families, but not for the phyllolitorin family. In 1979, a mammalian counterpart for BN was isolated from porcine gastric and intestinal tissues. This 27-amino acid peptide was the first BN-related peptide found in mammals, and was called GRP according to its activity originally found [5] . GRP regulates numerous gastrointestinal functions, such as the r e l e as e o f g a st r oi n t e s t i n a l h o r m o n e s [ 6 ] , stimulation of hormone secretion from the pancreas
, and smooth muscle cell contraction [10, 11] . In the female reproductive tract, GRP exhibits various physiological effects, such as control of epithelial ion transport in the endometrium [12] and modulation of uterine contraction [11] and also has effects on the proliferation and differentiation of the endometrium [13] . Furthermore, it serves as a cir cul at ing h or m on e i n fetal and uter ine development [14] , as a mitogenic agent [15] , and as an autocrine and paracrine regulatory peptide [16] i n th e u t e r u s . R a d i o i m m u n o a s s a y a n d immunohistochemical analysis revealed that GRPlike immunoreactivity was distributed in various tissues from a variety of mammalian species. These include gastrointestinal tissues [17] , brain [18] , pituitary gland [19] , spinal cord [20] , sensory and sympathetic ganglia [21, 22] , adrenal gland [23] , lung [24] , thyroid [25] and genitourinary tract [26] [27] [28] [29] . Moreover, some neuroendocrine tumors express GRP-like immunoreactivity, such as small cell lung carcinomas and medullary thyroid carcinomas [24, 30] .
I n t h e r e p r o d u c t i v e s y s t e m , G R P immunoreactivity has been detected during human pregnancy, predominantly in the trophoblasts of placental villi, extravillous trophoblasts and amniotic epithelial cells [27] . In sheep and cattle, it has been reported both in non-pregnant and pregnant animals, predominantly in the uterine g l a n d e p i t h e l i a l c e l l s [ 2 6 , 2 9 ] .
G R P immunoreactivity has also been detected in the superficial epithelial cells of the intercotyledonary endometrium of sheep [26] , the trophoblast, t ro p ho bl as ti c gian t c ell s, h ybr id c ell s and superficial epithelial cells of the caruncle of the cow [29] . Furthermore, since GRP mRNA is expressed only at day 16 in the estrous cycle of sheep, it was suggested that the appearance of GRP in uterine gland cells depends on the stage of the estrous cycle [31] . In the cervix, no report has so far been published on the localization and expression of GRP. This study was designed to clarify the localization of GRP and the expression of GRP mRNA in the bovine cervix.
Materials and Methods

Tissue samples
Cervix uteri from 21 non-pregnant and 20 pregnant cows and 6 fetuses were obtained from a local slaughterhouse as soon as possible after death ( Table 1 ). The cervix was separated into 3 parts: proximal, middle and distal parts. The proximal part is close to the uterine body, the distal part is close to the vagina, and the middle part is located between the proximal and distal parts. The tissues were fixed in Bouin's fluid for histological and immunohistochemical evaluations. For in situ hybridization, the cervix from the estrus stage and 2 months pregnant cows were cut into small blocks, embedded in OCT compounds (Miles Inc., Elkhart, USA), frozen in liquid nitrogen, and then stored at -80 C until use.
Immunohistochemistry
After fixation, the specimens were dehydrated in ethanol, cleared in xylene, and embedded in paraffin. Sections were cut serially in 5 µm thicknesses and stained by hematoxylin and eosin (HE) and periodic acid Shiff (PAS) for conventional histological evaluation. The estrous cycle stages (proestrus, estrus, metestrus and diestrus) were estimated based on the histological changes in the uterus in the cow as described by Priedkalns [32] . The fetal ages and pregnant periods were estimated b a s e d o n t h e c r o w n -r u m p -l e n g t h ( C R L ) (20-25 C) . The immunoreactive sites were visualized by the avidin-biotin peroxidase complex (ABC) method (Vectastain Elite ® ABC Kit; PK-6100, Vector La bo rat ories) a nd Tr is -H Cl buffer (pH 7 .4) containing 0.02% (w/v) 3,3'-diaminobenzidine tetrahydrochloride and 0.03% (v/v) H2O2. Stained sections were examined with a conventional light microscope, and photomicrographs were taken with a digital camera (Coolpix 950; Nikon, Tokyo, Japan). The intensities of GRP immunoreactivities in epithelial cells of the cervix were graded subjectively into 3 classes as shown in Table 2 . The specificity of the immunohistochemical staining w as c onfirmed by 2 co ntro l c onditio ns: (1) immunoabsorption of the primary antibody with a synthetic GRP (0.0001-100 µg/ml; R5553, Bachem, Torrance, CA, USA) prior to incubation of the section, and (2) the primary antibody was replaced with normal rabbit serum.
In situ hybridization
T w o n o n -o v e r l a p p i n g 4 5 -m e r a n t i se n s e oligonucleotide probes were synthesized for bovine GRP cDNA. The oligonucleotides were labeled with 35 S-dATP to a specific activity of 0.5 × 10 9 dpm/µg DNA, with terminal deoxynucleotidyl transferase (Promega, Madison, WI, USA). In situ h y b r i d i za t i o n a n a l y si s w a s p e r f o r m ed as previously described [34] . In brief, cryostat sections attached to the slideglass were fixed with 4% (w/v) paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) for 15 min, and then acetylated with 0 . 2 5 % ( v / v ) a c e t i c a n h y d r i d e i n 0 . 1 M t r i et ha n ol am i n e-H C l ( pH 8 . 0) fo r 1 0 m i n .
Hybridization was performed at 42 C for 10 h by adding 35 S-labeled oligonucleotide probes at a final concentration of 0.35 × 10 7 cpm/ml in 50% (v/v) formamide containing 30 mM Tris-HCl (pH 7.6), 0.6 M NaCl, 1 mM EDTA, 100 mM dithiothreitol, 1 × Denhardt's solution, 0.25% (w/v) sodium dodecyl sulfate (SDS), 10% (w/v) dextran sulfate and 200 µg/ml yeast tRNA. Control hybridization was performed in the presence of a 20-fold excess amount of unlabeled antisense probe. The slides were rinsed at room temperature for 30 min in 2 × SSC (1 × SSC: 150 mM NaCl and 15 mM sodium citrate) containing 0.1% (v/v) sarkosyl, twice at 55 C for 40 min in 0.1 × SSC containing 0.1% sarkosyl, dehydrated through a graded series of ethanol, and air dried. The slides were exposed to Hyperfilm β-max film (Amersham, Buckinghamshire, UK) for 2 weeks, or dipped into autoradiographic emulsion (NTB-2; Kodak, Rochester, NY, USA), exposed at 4 C f o r 4 w e e k s a n d c o u n t e r s t a i n e d w i t h hematoxylin. Sections were examined with a c o n v e n t i o n a l l i g h t m i c r o s c o p e , a n d photomicrographs were taken with a digital camera. * Crown-rump-length of fetus, Intensity of immunoreactivities: -, not detected; ±, very weak; +, weak; ++, moderate, The strong intensity (+++) of GRP immunoreactivity was deduced from the previous report of GRP immunolocalization in the uterine gland of pregnant cow [29] .
Results
The locations of epithelial cells in the cervix were shown by using the terminology for "central" and "peripheral" regions as well as "apical" and "basal" areas which occur within each of the regions. As shown in Fig. 1A , the term central region (1) was used to indicate the region in which the epithelial cells lined the central cervical canal, and peripheral region (2) to indicate the location of epithelial cells within the fold. The term basal area (3) was used to identify the location of epithelial cells within grooves, and apical area (4) to identify the area of epithelial cells between grooves (Fig.  1B) . Grooves were found both in central and peripheral regions.
Immunohistochemistry
In the fetuses, and adult non-pregnant and pregnant animals, GR P wa s predominantly immunolocalized in the epithelial cells of basal areas of peripheral regions of the cervix (Figs. 2, 3  and 4) . In contrast, no immunoreactivity for GRP was observed in the negative control. Table 2 summarizes the distribution and semiquantitative e v a l u a t i o n o f t h e i n te n s i t y o f G R P imm unor eact ivity in t he basal areas o f t he peripheral region of the bovine cervix.
During the prenatal period, GRP was first detected in the CRL 37 cm of the fetus (Fig. 2) . Weak GRP immunoreactivities were observed in the epithelial cells of the cervix until CRL 73 cm. D u r i n g th e e s t r o u s c y c l e ( F i g . 3 ) , G R P immunoreactivity in the epithelial cells of the cervix was weakly detected in the proximal, middle and distal parts in the proestrus stage. In the estrus stage, moderate GRP immunoreactivity was found in the epithelial cells of the cervix in the proximal and middle parts, and weak immunoreactivity in the distal part. Very weak GRP immunoreactivities were localized in the epithelial cells of all cervix parts both in the metestrus and diestrus stages. D u r i n g p r e g n a n c y , m o d e r a t e G R P immunoreactivities were localized in the epithelial cells of the cervix in the proximal and middle parts, and weak in the distal part of 2 (Fig. 4 ) and 3 months pregnant specimens. After 3 months of gestation, GRP immunoreactivity was not detected.
In situ hybridization
To ascertain the cellular localization of GRP m R N A e x p r e s si o n i n t h e c e r v i x , i n s i t u hybridization was carried out in estrus stage of the estrous cycle and 2 months pregnant animals (Fig.  5) . In situ hybridization with two non-overlapping antisense oligonucleotide pr obes exhibited consistent labeling in non-pregnant and pregnant samples. The specificity was confirmed by the disappearance of the signals when an excess dose of cold probe was added to the hybridization fluid. GRP mRNA was expressed predominantly in the epithelial cells of the cervix, as clearly shown on Xray films of the estrus stage and 2 months pregnant specimens. Light microscopic observation of a hybridized section (microautoradiography) also revealed strong labeling in the cervical epithelial cells of the estrus stage and 2 months pregnant cows. GRP mRNA was predominantly expressed in the epithelial cells of the basal areas of peripheral regions of the cervix. No significant signals were recognized in the cervix treated with the cold probe.
Discussion
I n t h e u t e r i n e h o r n a n d b o d y , G R P i m m u n o r e a c t i v i t y h a s b e e n l o c a l i z e d predominantly in the uterine gland epithelial cells of sheep [26] , humans [35] and cows [29] , and in the nerve fibers [29] . It was shown that GRP mRNA was expressed in the uterine gland cells [31] , indicating the in situ synthesis of GRP. In the cervix, GRP immunoreactivity was found in the nerve fibers running between the smooth muscle bundles and in the paracervical ganglia of the rat [36] . The present study, for the first time, provides evidence that GRP and its mRNA are present in the cervical epithelial cells. In cattle, GRP was first localized in a 37 cm fetus, and distributed with weak to moderate intensity in the follicular phase (proestrus and estrus stages) of the estrous cycle, and the second and third months of the gestation period. Moreover, the presence of GRP mRNA in the epithelial cells of the cervix of the estrus stage and 2 months pregnant animals was ascertained by in situ hybridization. These results indicate that the storage and synthesis of GRP in epithelial cells of the cervix is independent of the neuronal origin.
Ontogenetically, GRP immunoreactivity was first detected in the cervical epithelial cells of a CRL 37 cm (at about 5 months gestation) cattle fetus. It was known that the bovine uterus develops as a specialization of the paramesonephric ducts, which give rise to the infundibula, oviducts, uterus, cervix and anterior vagina [37] . Definitive uterine tissue layers are evident in cattle by 90-100th gestation day (about the 3rd month of the gestational period), follow by extensive prenatal morphogenesis [38] . Since in the CRL 28.5 cm (at about 4 months gestation) fetus, GRP immunoreactivity was not detected yet, it is likely that the GRP first appeared in the epithelial cells of the cervix about 2 months after the definitive uterine tissue was formed.
The expression of functional steroid receptors during the prenatal period is necessary for normal uterine develo pm ent [39 ] . N uc lear s ter oid receptors enhance target cell responsiveness to peptide growth factors [40] . Thus, expression of estrogen receptor (ER) in uterine cells later in development, as described for cows [39] , may define the point at which estrogen begins to elicit trophic effects on the fetal uterus and/or increase the sensitivity of ER uterine target cells to paracrine mediators of estrogen action such as isulin-like growth factor I or epidermal growth factor. Since GRP has also been known as growth factor in endometrial tissue [12, 13] , it may take part in further prenatal development of the uterus because of its proliferation and differentiation capacities, and/or acting as a paracrine mediator of estrogen action.
The main function of the bovine cervix is as a selective barrier for spermatozoa after mating, from where they are slowly released for passage to the rest of the genital tract. Sperm transport through the cervix is undoubtedly dependent upon both the structure of the cervical mucosa and the secretory pattern of cervical mucin [41] . The structure and composition of cervical mucus are being permissive to sperm transport only during the follicular phase of the estrous cycle [41] . The present study shows that the intensity of GRP immunoreactivity in the cervix during the follicular phase, a suitable time for sperm transport, is stronger than during the luteal phase (metestrus and diestrus stages). This result suggests that an important role of GRP for sperm transport, may be via regulation of mucus secretion in the cervix. The capacity of GRP as a mucus secretagogue has been reported in the nasal mucosal gland of humans in vivo [43, 44] and felines in vitro [45] . Secretory epithelium of the cervix comprising cells lining apical areas and those lining basal areas occur in the central and peripheral regions [41] . In addition, it has been shown that sperm deepest within the cervical mucosa (basal areas of peripheral regions) were more viable and most likely to transit to the uterus [41, 46] . The present study clarifies the GRP localization and G R P m R N A ex pr es s i o n d o m in an t ly in t h e epithelial cells of basal areas of peripheral regions, where it coincides with suitable parts of the cervix for sperm transport from the vagina to the uterine cavity. During pregnancy, cervical mucus plugs are generated by the same cervical epithelial cells that produce mucus in non-pregnant women [47] . The cervical mucus plug is an important physical barrier to microbial entry into the uterine cavity [48] . GRP immunoreactivity and GRP mRNA in the epithelial cells of the cervix during the early gestation periods detected in this study could be still in correlation with its role in mucus secretory activity to form the plug. The absence of GRP immunoreactivity after 3 months of gestation suggests that a definite cervical mucus plug has already formed and further secretory regulation by GRP is not needed. Furthermore, the stronger GRP immunoreactivity in the proximal and middle parts compared with the distal part of the cervix during the estrus stage, and 2 and 3 months gestation stages is not surprising, since the secretory activity close to the protected part could be greater than that in the more distant ones.
In conclusion, the present study clarifies the presence of GRP and GRP mRNA in the bovine cervix, and suggests that GRP may play a role in the ea rly development of the cervix and mucus secretory activity of epithelial cells of the cervix.
